PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: LifeSensors, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Cayman Chemical Licenses LifeSensors’ SUMO Platforms Launches New Products - Cayman Chemical Company, Inc. and LifeSensors, Inc. signed a technology license agreement granting Cayman non-exclusive rights to LifeSensors’ protein expression technologies - LifeSensors.com / CaymanChem.com
Cayman Chemical Licenses LifeSensors’ SUMO Platforms Launches New Products

 

NewswireToday - /newswire/ - Malvern, PA, United States, 2011/11/21 - Cayman Chemical Company, Inc. and LifeSensors, Inc. signed a technology license agreement granting Cayman non-exclusive rights to LifeSensors’ protein expression technologies - LifeSensors.com / CaymanChem.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cayman continues to expand its product line, now utilizing LifeSensors’ protein expression SUMOpro™ and SUMOstar™ platforms. More products are in the pipeline and scheduled for release in coming months. Several thousand Cayman research kits and specialty chemicals are prepared and tested by Cayman in Michigan before being distributed to scientists throughout the world.

Discovered and developed by LifeSensors, Small Ubiquitin-like MOdifier (SUMO) expression systems (1) enhance the quantity of protein by preventing nascent protein degradation; (2) enhance the quality of protein by acting as a nucleation site for proper folding of target proteins; (3) enhance solubility via the hydrophilic C- and N-termini; and (4) facilitate simple purification using SUMO proteases that cleave all junctions to generate native N-termini.

As cost-effective solutions for routine and rare protein production, the scalability of SUMOpro™ and SUMOstar™ platforms also accommodates growth from research grade processes to industrial and commercial manufacturing. By enhancing expression, folding and solubility of recombinant peptides and proteins, SUMO-fusions simplify optimization steps. Scientists are free to optimize their production in prokaryotes and in eukaryotes – both intracellular and secretory cells.

LifeSensors, Inc. (lifesensors.com) develops technologies that utilize SUMO to overcome bottlenecks in protein production. SUMO protein production platforms have been used to manufacture industrial, research and therapeutic proteins. LifeSensors also offers technologies and tools to study the Ubiquitin-Proteasome Pathway. For more information about LifeSensors, visit our website, follow us on Twitter (twitter.com/LifeSensorsInc), call, or email.

Cayman Chemical Company, Inc. (caymanchem.com) is a manufacturer, supplier and vendor of biochemical reagents, assay kits, antibodies and proteins for the advancement of human and veterinary healthcare. With a diverse product line of 4000+ different biochemicals our goal is to "Help Make Research Possible”.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: LifeSensors, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Cayman Chemical Licenses LifeSensors’ SUMO Platforms Launches New Products

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Asim Malik - LifeSensors.com 
610-644-8845 x341 bd[.]lifesensors.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any LifeSensors, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From LifeSensors, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)